As rotating shield brachytherapy (RSBT) is a time-critical application, with the patient waiting for the treatment under general anesthesia. An efficient inverse planning system is need for making this technique practical. Existing dose optimization methods either take long time to reach a desired solution (e.g., simulated annealing), or make a compromise on the quality of the plan (e.g., using surface-based optimization instead of dose-volume based optimization). Moreover, to reveal the "best" tradeoff between the dose quality and the delivery time, we need to assess the dose quality for each possible delivery configuration quickly. However, the delivery configuration (i.e. azimuthal emission angle δφ in this study) may vary significantly between cases, and dose-volume optimization with simulated annealing takes about 20 minutes for each delivery configuration in our initial study. Therefore, it is unlikely to make repeated dose-volume optimization for each delivery configuration in clinical practices.
We address this problem by decoupling the dose optimization and the plan delivery. For each of the two clinical cases used in this study, an anchor plan which maximizes the minimum dose received by the hottest 90% of the tumor (D 90 ) to the tumor but with infeasible delivery time is generated. This anchor plan uses micro-azimuthal-angle δφ as the azimuthal emission angle, and the dose-volume optimization is done with simulated annealing. Solutions from surfacebased optimization are used as initial solutions to speed up the optimization procedure. The whole optimization procedure takes about 20 minutes to finish. The RSBT emission angle selector determines the optimal emission angle for a given case by combining neighboring beamlets from the anchor plan to form the beamlets corresponding to larger emission angles ∆φ=Wδφ (W>1). The delivery times for each beam direction for the larger emission angles are determined by efficiently solving a globally-optimal quadratic programming problem that closely reproduces the angular distribution of beam intensities from the anchor plan. The dosimetric quality assessment for each emission angle ∆φ takes less than one second. A Pareto plot of the dosimetric plan quality metric, such as D 90 versus the delivery time, is generated for the clinicians (Examples are shown in Figure 1) . Therefore, the clinicians can determine the most appropriate emission angle for a given patient by considering the tradeoff between the dose quality and the delivery time. In this work two cervical cancer cases were considered to test the emission angle selection algorithm. The RSBT system was assumed to be a Xoft Axxent TM electronic brachytherapy source with a 0.2 mm tungsten shield. The intent for each treatment plans was to maximize tumor D 90 while respective the GEC-ESTRO recommended constraints on the D 2cc values to the bladder, rectum, and sigmoid colon of 90, 75, and 75 Gy 3 , respectively, which includes the dose from external beam radiotherapy (EBRT). 
